MarketAxess Holdings Inc. (MKTX) has expanded its partnership with Arcesium by integrating its CP+ and TraX datasets into Arcesium's platforms, enabling institutional clients to access pricing, liquidity, and transaction data within their existing workflows. Building on the existing Repo Match service that handles over $700 billion in daily volume, this integration aims to strengthen MKTX's data and analytics business and create new monetization opportunities. However, MKTX shares have underperformed year-to-date, falling 9.3% against the industry's 0.9% growth.

BGC Group and MarketAxess are compared as potential value stock investments in the Financial - Investment Bank sector. BGC Group emerges as the superior value option with a Zacks Rank of #2 (Buy) versus MarketAxess's #3 (Hold), supported by a lower forward P/E ratio of 8.56 compared to 20.36, and a better Value grade of B versus D.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).

MarketAxess (MKTX) is diversifying beyond U.S. credit with international expansion and new trading protocols, with non-U.S. credit revenues rising 9%. However, U.S. credit revenues declined 9%, and the stock carries an elevated forward P/E of 19.08X above industry average. The company maintains strong financials and consistent earnings beats, but faces risks from trading volume sensitivity and investment costs, warranting a neutral stance.

Law firm Wohl & Fruchter is investigating whether the proposed sale of MarketAxess to Intercontinental Exchange at $167.00 per share is fair to shareholders, given the stock's 52-week high of $200.90 and a recent UBS price target of $200.00. Shareholders have expressed concerns that the deal undervalues the company.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.

Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.

MarketAxess reported record Q2 2025 revenue of $219.5 million, growing 11% year-over-year, with Non-GAAP EPS of $2.00. The company saw significant trading volume increases across various bond market segments, while experiencing margin pressure from evolving trading protocols.

The article highlights three finance stocks positioned to benefit from market volatility in 2025, focusing on derivatives trading, investment banking, and electronic bond trading platforms.

The article discusses three growth stocks - MarketAxess, Amplitude, and Cintas - that have shown consistent revenue, net income, and free cash flow growth, making them attractive investment options for those looking to grow their wealth for a comfortable retirement.

Morgan Stanley has upgraded three financial stocks - Cboe Global Markets, CME Group, and MarketAxess Holdings - as investors seek to hedge risk and rebalance portfolios amid market uncertainty.